Kureha entered the field of pharmaceuticals in 1977. The development of Krestin, an anti-cancer agent that aims to boost immunity and eliminate cancer, was based on the expertise and know-how gained from the field of food sciences. Kremezin, a therapeutic agent for chronic kidney disease is a unique spherical adsorptive carbon that utilizes carbon material technology and is now a mainstay in the field of pharmaceuticals.

Kureha will continue to develop medicines based on both immunity evaluation technology and adsorption technology.